Pethidinic acid

Pethidinic acid (meperidinic acid, pethidine intermediate C) is a 4-phenylpiperidine derivative that is both a metabolite of and a precursor to pethidine (meperidine).[2][3] It is scheduled by UN Single Convention on Narcotic Drugs. It is a Schedule II Narcotic controlled substance in the United States and has an ACSCN of 9234. The 2014 annual manufacturing quota was 6 grams. [4]

Pethidinic acid
Clinical data
Routes of
administration		N/A
ATC code
  • none
Legal status
Legal status
Identifiers
  • 1-methyl-4-phenylpiperidine-4-carboxylic acid
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC13H17NO2
Molar mass219.284 g·mol−1
3D model (JSmol)
  • CN1CCC(CC1)(C2=CC=CC=C2)C(=O)O
  • InChI=1S/C13H17NO2/c1-14-9-7-13(8-10-14,12(15)16)11-5-3-2-4-6-11/h2-6H,7-10H2,1H3,(H,15,16) ☒N
  • Key:KHUPPYUUMRDAAX-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)


Pethidinic acid is a controlled drug because of its potential uses in manufacturing both pethidine itself and some of its substituted derivatives, but it has little opioid activity in its own right. Metabolism of pethidine to pethidinic acid is carried out mainly by the carboxylesterase enzyme hCE-1 in the liver,[5] and since the activity of this enzyme can vary between individuals, the rate and extent of pethidinic acid production can vary.[6][7]

Frank Wätjen used pethidinic acid as a precursor chemical to a heterocyclic moiety.[8]

See also

References
  1. Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
  2. Tompsett SL (1962). "The detection and determination of pethidinic acid in urine". Acta Pharmacologica et Toxicologica. 19: 368–70. PMID 13985467.
  3. Chan K, Lau OW, Wong YC (April 1991). "Determination of pethidine and its major metabolites in human urine by gas chromatography". Journal of Chromatography. 565 (1–2): 247–54. doi:10.1016/0378-4347(91)80387-R. PMID 1874871.
  4. "Conversion Factors for Controlled Substances". DEA Diversion Control Division. Drug Enforcement Agency, U.S. Department of Justice.
  5. Zhang J, Burnell JC, Dumaual N, Bosron WF (July 1999). "Binding and hydrolysis of meperidine by human liver carboxylesterase hCE-1". The Journal of Pharmacology and Experimental Therapeutics. 290 (1): 314–8. PMID 10381793.
  6. Wainer IW, Stambaugh JE (January 1978). "GLC determination of meperidinic and normeperidinic acids in urine". Journal of Pharmaceutical Sciences. 67 (1): 116–8. doi:10.1002/jps.2600670131. PMID 619098.
  7. Odar-Cederlöf I, Boréus LO, Bondesson U, Holmberg L, Heyner L (1985). "Comparison of renal excretion of pethidine (meperidine) and its metabolites in old and young patients". European Journal of Clinical Pharmacology. 28 (2): 171–5. doi:10.1007/BF00609687. PMID 3987796. S2CID 20800555.
  8. EP 0285032, Wätjen, Frank, "4-Phenylpiperidine compounds and their preparation and use", published 1988-10-05, assigned to Ferrosan A.S.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.